Skip to main content
    Q

    Q32 Bio Inc (QTTB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.77
    -0.24 (-3.00%)

    Market Cap: $238.45M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(14/34)
    Avg Surprise
    -631.64%
    Streak
    7 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.34
    Range$-0.42 - $-0.27
    6 analysts
    EPS Revisions
    2
    0
    7d
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.41+17.5%
    60d ago$-0.38+12.3%
    30d ago$-0.33-3.1%
    7d ago$-0.33-0.9%
    Current$-0.34
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.04
    Range$-0.08 - $0.19
    6 analysts
    Revenue Consensus
    $-200000
    Range$-600000 - $1M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.04---
    Sep 26EST
    		-$-0.34---
    Jun 26
    Reported Aug 5
    		$-0.44$-0.53+16.98%Beat+43.6%
    Mar 26
    Reported May 5
    		$-0.54$-0.68+20.59%Beat+40.0%
    Dec 25
    Reported Mar 10
    		$4.58$-0.86+632.56%Beat+494.8%
    Sep 25
    Reported Nov 13
    		$-0.60$-1.19+49.58%Beat+58.9%
    Jun 25
    Reported Aug 6
    		$-0.78$-0.98+20.41%Beat+45.1%
    Mar 25
    Reported May 8
    		$-0.90$-1.23+26.83%Beat-187.4%
    Dec 24
    Reported Mar 11
    		$-1.16$-1.53+24.18%Beat-314.3%
    Sep 24
    Reported Nov 7
    		$-1.46$-1.45-0.69%Miss-156.1%
    Jun 24
    Reported Aug 8
    		$-1.42$-1.04-36.54%Miss-132.8%
    Mar 24
    Reported May 9
    		$1.03$-1.41+173.05%Beat+306.0%
    Dec 23
    Reported Mar 13
    		$-0.28$-0.30+6.67%Beat+97.4%
    Sep 23
    Reported Nov 14
    		$-0.57$-0.43-32.56%Miss+94.6%
    Jun 23
    Reported Jul 27
    		$-0.61$-0.50-22.00%Miss+93.4%
    Mar 23
    Reported May 11
    		$-0.50$-0.52+3.85%Beat-101.7%
    Dec 22
    Reported Mar 29
    		$-10.80$-0.49-2094.23%Miss-1.7%
    Sep 22
    Reported Dec 29
    		$-10.62$-0.46-2226.91%Miss-9.3%
    Jun 22
    Reported Sep 28
    		$-9.18$-0.54-1607.59%Miss+5.6%
    Mar 22
    Reported Jun 28
    		$28.62$-0.49+5909.99%Beat+8050.0%
    Dec 21
    Reported Mar 29
    		$-10.62$-0.57-1748.89%Miss+4.8%
    Sep 21
    Reported Dec 29
    		$-9.72$-0.59-1555.88%Miss+12.9%
    Jun 21
    Reported Sep 28
    		$-9.72$-0.57-1590.43%Miss+30.8%
    Mar 21
    Reported Jun 28
    		$-0.36$-0.61+41.35%Beat+97.4%
    Dec 20
    Reported Mar 30
    		$-11.16$-0.66-1593.99%Miss-12.7%
    Sep 20
    Reported Nov 9
    		$-11.16$-0.81-1279.82%Miss+7.5%
    Jun 20
    Reported Aug 10
    		$-14.04$-0.74-1797.30%Miss-27.9%
    Mar 20
    Reported Jun 29
    		$-14.04$-0.69-1934.78%Miss-21.9%
    Dec 19
    Reported Mar 30
    		$-9.90$-0.68-1355.88%Miss-7.8%
    Sep 19
    Reported Nov 12
    		$-12.06$-0.60-1910.00%Miss-67.5%
    Jun 19
    Reported Aug 8
    		$-10.98$-0.55-1896.36%Miss-6762.5%
    Mar 19
    Reported Jun 29
    		$-11.52$-0.54-2033.33%Miss-7580.0%
    Dec 18
    Reported Mar 30
    		$-9.18$-0.44-1986.36%Miss-2768.7%
    Sep 18
    Reported Nov 13
    		$-7.20$-0.37-1845.95%Miss-
    Jun 18
    Reported Aug 13
    		$-0.16N/A+51.52%Beat-
    Mar 18
    Reported Jun 29
    		$-0.15N/A+96.03%Beat-
    Dec 17
    Reported Mar 30
    		$-0.32$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio2.59EV/EBITDA1.51x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin62.90%Operating Margin39.90%
    ROE72.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio20.30xQuick Ratio20.30x
    Trading Statistics
    Beta-0.11Avg Volume1.10M
    52-Week High$23.5752-Week Low$1.91

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.17
    SMA 20$8.81
    SMA 50$12.00
    SMA 200$8.95
    EMA 10$8.29
    EMA 20$9.02
    EMA 50$10.79
    EMA 200$9.41

    MACD

    Line: -1.09Signal: -1.21Hist: 0.12

    ADX

    ADX: 42.7+DI: 14.5-DI: 29.8

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down80.0
    PSAR$9.68

    Bollinger Bands

    Upper Band$10.62
    Lower Band$6.99
    %B Position4116%(Upper)
    Band Width0.21

    RSI (14-Day)

    Oversold
    29.2

    Momentum Oscillators

    Stoch %K11.8
    Stoch %D19.8
    Williams %R-94.6
    ROC (10d)-5.8%
    Momentum-0.48
    CCI (20d)-85.1
    MFI (14d)29.8

    Volatility Measures

    ATR (14d)$0.75(9.7%)
    StdDev (20d)0.91
    Hist Vol74.8%(High)

    Volume Flow

    VWAP$7.92
    OBV244.1M
    AD Line-113.2M
    CMF (20d)-0.284

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.5x
    VWMA (20d)$8.59

    Pivot Points

    R3$8.88
    R2$8.59
    R1$8.30
    Pivot Point$8.01
    S1$7.72
    S2$7.43
    S3$7.14

    Advanced Oscillators

    TSI-43.41
    Ultimate Osc44.1
    KST-323.57

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$53.74M$0$0$0$0$0$0$0$-14,662,000$1.86M
    Cost of Revenue$0$0$90,000$0$0$0$120,000$0$0$0$124,000$0
    Gross Profit$0$0$53.74M$0$0$0$-120,000$0$0$0$-14,662,000$1.86M
    Operating Expenses$9.12M$7.72M$7.86M$7.58M$9.17M$12.23M$14.53M$18.81M$17.92M$14.84M$11.15M$9.66M
    R&D$4.26M$3.22M$3.32M$3.56M$5.16M$7.12M$10.54M$14.35M$13.41M$9.84M$8.34M$7.46M
    SG&A$4.86M$4.50M$4.54M$4.02M$4.01M$5.10M$3.98M$4.47M$4.51M$5.00M$2.81M$2.19M
    Operating Income$-9,118,000$-7,722,000$45.88M$-7,577,000$-9,171,000$-12,228,000$-14,526,000$-18,814,000$-17,919,000$-14,843,000$-25,809,000$-7,798,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$147,000$0$0$0$0$0$0$0$0$0$1.00M$6.17M
    Income Before Tax$-8,946,000$-7,609,000$57.73M$-7,389,000$-9,489,000$-11,031,000$-14,168,000$-17,595,000$-15,529,000$1.21M$-26,814,000$-13,966,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-8,946,000$-7,609,000$57.73M$-7,389,000$-9,489,000$-11,031,000$-14,189,000$-17,595,000$-16,978,000$1.03M$-27,067,000$-14,031,000
    EBITDA$-8,781,000$-7,486,000$57.86M$-7,252,000$-9,349,000$-10,864,000$-13,999,000$-17,437,000$-15,548,000$1.36M$-26,660,000$-13,835,000
    EBIT$-8,799,000$-7,609,000$57.73M$-7,389,000$-9,489,000$-11,031,000$-14,168,000$-17,595,000$-15,529,000$1.21M$-26,814,000$-13,966,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about QTTB

    QTTB Valuation and Fair Value

    P/E
    2.6x
    EV/EBITDA
    1.5x
    P/B
    1.5x
    See GNG's fair value

    QTTB Profitability: Margins, ROIC and FCF

    Operating margin
    39.9%
    Net margin
    62.9%
    ROE
    72.1%
    FCF margin
    -36.9%

    QTTB Competitors

    CompanyTicker
    Fate Therapeutics IncFATE
    Utah Medical Products IncUTMD
    TriSalus Life Sciences Inc.TLSI
    Immuneering CorpIMRX
    Profound Medical CorpPROF
    High Tide IncHITI
    Rocket Pharmaceuticals IncRCKT
    Lineage Cell Therapeutics IncLCTX

    Sector: Healthcare

    QTTB Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    1
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    QTTB Bull Case vs Bear Case

    Bull case

    • QTTB has a 62.9% net profit margin.
    • QTTB beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 100.0% of QTTB's analyst ratings are Buy or Strong Buy.

    QTTB Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    98.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.34
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 1 down

    Frequently Asked Questions About QTTB

    Does QTTB pay dividends?

    Q32 Bio Inc (QTTB) does not currently pay a regular dividend.

    What is QTTB's P/E ratio?

    Q32 Bio Inc has a price-to-earnings (P/E) ratio of 2.59.

    What is QTTB's market cap?

    Q32 Bio Inc (QTTB) has a market capitalization of $238.45M with a current stock price of $7.77.

    Related stocks

    Sector: Healthcare

    All stocks starting with Q

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In